TABLE 1.
Subjects | Treatment | Outcome | Authors, year |
---|---|---|---|
Alzheimer's disease | |||
3 × Tg‐AD† mice |
Lactobacillus plantarum PS128 |
|
Huang et al., 2021 47 |
15–17 months old Lister Hooded rats | Lactobacillus acidophilus CUL60, Lactobacillus acidophilus CUL21, Bifidobacterium bifidum CUL20, and Bifidobacterium lactis CUL34 |
|
O'Hagan et al., 2017 48 |
Aβ†‐injected ddY mice | Bifidobacterium breve A1 |
|
Kobayashi et al., 2017 49 |
D‐galactose‐injected Wistar rats |
Lactobacillus plantarum MTCC1325 |
|
Nimgapalle and Kuna, 2017 50 |
3 × Tg‐AD† mice |
SLAB51 formulation: Streptococcus thermophilus, Bifidobacterium. longum, Bifidobacterium breve, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus. paracasei, Lactobacillus delbrueckii subsp. bulgaricus, Lactobacillus brevis |
|
Bonfilli et al., 2017 51 |
Aβ†‐injected Wistar rats | Lactobacillus acidophilus, Lactobacillus fermentum, Bifidobacterium lactis, and Bifidobacterium longum |
|
Athari et al., 2018 52 |
5XFAD Tg mice | Lactobacillus plantarum C29 |
|
Lee et al., 2021 53 |
AD† patients | Lactobacillus acidophilus, Lactobacillus casei, Bifidobacterium bifidum, and Lactobacillus fermentum |
|
Akbari et al., 2016 54 |
AD† patients | Lactobacillus fermentum, Lactobacillus plantarum, Bifidobacterium lactis, Lactobacillus acidophilus, Bifidobacterium bifidum, and Bifidobacterium longum |
|
Agahi et al., 2018 55 |
AD† patients | Lactobacillus casei W56, Lactococcus lactis W19, Lactobacillus acidophilus W22, Bifidobacterium lactis W52, Lactobacillus paracasei W20, Lactobacillus plantarum W62, Bifidobacterium lactis W51, Bifidobacterium bifidum W23 and Lactobacillus salivarius W24 |
|
Leblhuber et al., 2018 56 |
AD† patients | Lactobacillus acidophilus, Bifidobacterium bifidum, Bifidobacterium longum, and selenium |
|
Tamtaji et al., 2019 57 |
Parkinson's disease | |||
MitoPark PD† mice | Bifidobacterium bifidum, Bifidobacterium longum, Lactobacillus rhamnosus, Lactobacillus rhamnosus GG, Lactobacillus plantarum LP28, and Lactococcus lactis subsp. lactis |
|
Hsieh et al., 2020 58 |
MPTP†‐induced PD† in C57BL/6 mice | Lactobacillus rhamnosus GG, Bifidobacterium animalis lactis, and Lactobacillus acidophilus |
|
Srivastav et al., 2019 59 |
6‐OHDA†‐induced PD† in C57BL/6 mice | SLAB51 formulation |
|
Castelli et al., 2020 60 |
MPTP†‐induced PD† in C57BL/6 mice | Lactobacillus plantarum CRL2130, Streptococcus thermophilus CRL807, and Streptococcus thermophilus CRL808 |
|
Perez Visnuk et al., 2020 61 |
PD† patients | Lactobacillus acidophilus and Bifidobacterium infantis |
|
Georgescu et al., 2016 62 |
PD† patients | Enterococcus faecium, Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus rhamnosus, Bifidobacterium longum, Bifidobacterium bifidum, and Lactobacillus reuteri |
|
Tan et al., 2021 63 |
PD† patients | Lactobacillus casei Shirota |
|
Cassani et al., 2011 64 |
PD† patients | Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus reuteri, and Lactobacillus fermentum |
|
Borzabadi et al., 2018 65 |
PD† patients | Streptococcus salivarius subsp. thermophilus, Enterococcus faecium, Lactobacillus rhamnosus GG, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus delbrueckii subsp bulgaricus, and Bifidobacterium (breve and animalis subsp. lactis |
|
Barichella et al., 2016 66 |
Depression | |||
Mice exposed to chronic restraint stress | Bifidobacterium adolescentis |
|
Guo et al., 2019 67 |
Corticosterone‐induced depression in mice | Lactobacillus paracasei PS23, live or heat‐killed | Live PS23:
|
Wei et al., 2019 68 |
Healthy Swiss mice | Lactobacillus plantarum 286 |
|
Barros‐ Santos et al., 2020 69 |
Wistar rats exposed to chronic unpredictable mild stress | Lactobacillus rhamnosus JB‐1 |
|
Kochalska et al., 2020 70 |
C57BL/6J mice exposed to chronic stress | Bifidobacterium breve CCFM1025 |
|
Tian et al., 2020 71 |
Corticosterone‐induced depression in Sprague–Dawley rats | Lactobacillus plantarum DP189 |
|
Zhao et al., 2020 72 |
Lipopolysaccharide‐induced anxiety in adolescent CD1 mice | BGOS† |
|
Savignac et al., 2016 73 |
C57BL/6J mice exposed to chronic psychosocial stress | FOS† + GOS† |
|
Burokas et al., 2017 74 |
Sprague–Dawley rats exposed to chronic unpredictable mild stress | FOS† |
|
Chi et al., 2020 75 |
C57BL/6J mice exposed to subchronic and mild social defeat stress | Heat‐killed Lactobacillus helveticus strain MCC1848 |
|
Maehata et al., 2019 76 |
Healthy C57BL/6 mice | Heat‐killed Lactobacillus fermentum and Lactobacillus delbrueckii |
|
Warda et al., 2019 77 |
Healthy C57BL/6J mice | Heat‐killed Enterococcus faecalis strain EC‐12 |
|
Kambe et al., 2020 78 |
Adults with moderate mood swings | Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 |
|
Romijn et al., 2017 79 |
Moderately stressed adults | Lactobacillus plantarum DR7 |
|
Chong et al., 2019 80 |
Moderately stressed adults | Lactobacillus plantarum P8 |
|
Lew et al., 2019 81 |
Healthy adults | Heat‐killed Lactobacillus paracasei MCC1849 |
|
Murata et al., 2018 82 |
Young adult students preparing for the national examination | Heat‐inactivated Lactobacillus gasseri CP2305 |
|
Nishida et al., 2019 83 |
Patients with major depressive disorder | Lactobacillus plantarum 299v + SSRI |
|
Rudzki et al., 2019 84 |
Adult patients with moderate depression | Lactobacillus casaei + Lactobacillus acidofilus + Lactobacillus bulgarigus + Lactobacillus rhamnosus + Bifidobacterium breve + Bifidobacterium longum + Streptococcus thermophilus + FOS + fluoxetine |
|
Ghorbani et al., 2018 85 |
Adult patients with mild‐to‐moderate depression |
Lactobacillus helveticus Rosell® − 52 + Bifidobacterium longum Rosell® − 175 + SAMe† + magnesium oxide + vitamin B6 |
|
Ullah et al., 2022 86 |
Adult patients with major depressive disorder |
Freeze‐dried Bifidobacterium breve CCFM1025 |
|
Tian et al., 2022 87 |
Schizophrenia | |||
Sprague Dawley rats | BGOS† + olanzapine |
|
Kao et al., 2018 88 |
C57BL/6 mice on a high‐fat diet | Akkermansia muciniphilasub (Akk I subtype, GP01 strain) + olanzapine |
|
Huang et al., 2021 89 |
Sprague Dawley rats | FOS† + GOS† |
|
Savignac et al., 2013 90 |
BALB/c mice | Lactobacillus rhamnosus JB‐1 |
|
Janik et al., 2016 91 |
C57BL/6J mice | FOS† + GOS† |
|
Burokas et al., 2017 92 |
Sprague Dawley rats | BGOS† |
|
Gronier et al., 2018 93 |
SCZ† patients | Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis Bb12 |
|
Dickerson et al., 2014 94 |
Patients with SCZ† and schizoaffective disorder | Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis Bb12 |
|
Tomasik et al., 2015 95 |
SCZ† patients | Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis Bb12 |
|
Severance et al., 2017 96 |
Bipolar disorder | |||
BD† patients | Bifidobacterium bifidum, Bifidobacterrium lactis, Bifidobacterium longum, and Lactobacillus acidophilus |
|
Shahrbabaki et al., 2020 97 |
BD† patients |
Lactobacillus casei W56, Lactobacillus acidophilus W22, Lactobacillus paracasei W20, Bifidobacterium lactis W51, Lactobacillus salivarius W24, Lactococcus lactis W19, Bifidobacterium lactis W52, Lactobacillus plantarum W62, Bifidobacterium bifidum W23 |
|
Reininghaus et al., 2020 98 |
Abbreviations: AD, Alzheimer's disease; AchE, acetylcholine esterase; Ach, acetylcholine; ALT, alanine‐transaminase; AST, aspartate‐transaminase; Aβ, amyloid beta; BD, bipolar disorder; BDNF, brain‐derived neurotrophic factor; B‐GOS, Bimuno™ galacto‐oligosaccharide; CBM, complete bowel movements; CRP, C‐reactive peptide; FOS, fructo‐oligosaccharides; GIP, gastric inhibitory polypeptide; GOS, galacto‐oligosaccharides; GSH, glutathione; HAM‐D, Hamilton Depression Rating Scale; HDRS‐24, Hamilton Depression Rating scale‐24 Items; MADRS, Montgomery‐Asberg Depression Rating Scale; MAO‐B, monoamine oxidase B; MDA‐ malondialdehyde; MMSE, Mini‐Mental State Examination; MPTP, 1‐methyl‐4‐phenyl‐1,2,3,6,‐tetrahydropyridine; NMDA, N‐methyl–D‐aspartate; PANSS, Positive and Negative Syndrome Scale; PD, Parkinson's disease; PHQ‐9, Patient Health Questionnaire‐9; PPARγ, peroxisome proliferator‐activated receptor gamma; SAMe, S‐adenosyl‐L‐methionine disulfate p‐toluenesulfonate; SBM, spontaneous bowel movements; SCFAs, short‐chain fatty acids; †SCZ, schizophrenia; SOD, superoxide‐dismutase; TAC, total antioxidant capacity; TH, tyrosine hydroxylase; TYM, Test Your Memory; 6‐OHDA, 6‐hydroxydopamine.